Apply for Funding
CPRIT offers several funding opportunities for promising cancer research, product development, and prevention programs. All funding opportunities are announced through formal Requests for Applications (RFAs) and applications must be submitted through the online application receipt system.
Learn more about the grants process.
TREC: Pilot Study Award (TREC-PSA)
Program | Academic Research |
RFA Status | Open |
Description |
Provides short-term funding to explore the feasibility of cancer research projects at TREC-eligible institutions that, if successful, would contribute new insights into the etiology, diagnosis, treatment, or prevention of cancers, forming the basis for applications for peer-reviewed funding from CPRIT or other organizations.
Award: Up to $100,000 per year for a period of up to 2 years |
Review Cycle | Fiscal Year 2025 - Cycle 2 |
RFA Release | August 28, 2024 |
Application Receipt | September 18, 2024 - December 10, 2024 |
Application Review | March 2025 |
Award Notification | May 2025 |
TREC: Advancing Innovative Individual Research Awards at TREC-Eligible Institutions (TREC-AIIRA)
Program | Academic Research |
RFA Status | Open |
Description |
Supports research projects addressing critically important questions, that will significantly advance knowledge of the causes, prevention, and/or treatment of cancer. This award allows cancer researchers at all career stages the opportunity to explore new methods and approaches for investigating a question of importance that has been inadequately addressed or for which there may be an absence of an established paradigm or technical framework.
Award: Up to $250,000 per year for a period of up to 3 years |
Review Cycle | Fiscal Year 2025 - Cycle 2 |
RFA Release | August 28, 2024 |
Application Receipt | September 18, 2024 - December 10, 2024 |
Application Review | March 2025 |
Award Notification | May 2025 |
TREC: Core Facility Support Awards (TREC-CFSA)
Program | Academic Research |
RFA Status | Open |
Description |
Supports applications that facilitate the development of new core facilities or improvement of existing core facilities that will provide valuable services to support and enhance scientifically meritorious cancer research projects at TREC-eligible institutions. CPRIT will look with special favor on applications that propose a facility that will serve cancer researchers at multiple Texas research institutions, in particular TREC-eligible institutions.
Award: Up to $400,000 per year for a period of up to 5 years |
Review Cycle | Fiscal Year 2025 - Cycle 2 |
RFA Release | August 28, 2024 |
Application Receipt | September 18, 2024 - December 10, 2024 |
Application Review | March 2025 |
Award Notification | May 2025 |
Early Clinical Investigator Awards (ECI)
Program | Academic Research |
RFA Status | Open |
Description |
Supports cancer physicians early in their academic career in developing clinical research skills, and gaining experience in advanced methods and experimental approaches needed to become clinical investigators; to establish a partnership with a laboratory-based collaborator to design and conduct correlative studies needed to interpret the outcome of an interventional trial; to provide the protected time to develop and conduct investigator-initiated clinical trials; and to increase the pool of clinical investigators at Texas academic institutions who are conducting patient-oriented studies, involving cancer patients or individuals at risk for cancer.
Award: Up to $200,000 per year for a period of up to 5 years |
Review Cycle | Fiscal Year 2025 - Cycle 2 |
RFA Release | August 28, 2024 |
Application Receipt | September 18, 2024 - December 10, 2024 |
Application Review | March 2025 |
Award Notification | May 2025 |
High-Impact/High-Risk Research Awards (HIHR)
Program | Academic Research |
RFA Status | Open |
Description |
Supports applications that explore the feasibility of high-risk projects that, if successful, would contribute major new insights into the etiology, diagnosis, treatment, or prevention of cancers. Using this mechanism, CPRIT intends to support innovative, developmental projects that focus on exceptionally promising topics that are not yet sufficiently mature to compete successfully for more conventional funding. The HIHR Research Awards are expected to provide the foundation and preliminary data for individual or multiple investigator peer-reviewed awards.
Award: Up to $125,000 per year for a period of up to 24 months |
Review Cycle | Fiscal Year 2025 - Cycle 2 |
RFA Release | August 28, 2024 |
Application Receipt | September 18, 2024 - December 10, 2024 |
Application Review | March 2025 |
Award Notification | May 2025 |
Core Facility Support Awards (CFSA)
Program | Academic Research |
RFA Status | Open |
Description |
Supports applications that facilitate the development of new core facilities or improvement of existing core facilities that will provide valuable services to support and enhance scientifically meritorious cancer research projects. CPRIT will look with special favor on applications that propose a facility that will serve cancer researchers at multiple Texas research institutions, in particular TREC-eligible institutions.
Award: Up to $600,000 per year for new applications and up to $400,000 per year for renewal applications for a period of up to 5 years |
Review Cycle | Fiscal Year 2025 - Cycle 2 |
RFA Release | August 28, 2024 |
Application Receipt | September 18, 2024 - December 10, 2024 |
Application Review | March 2025 |
Award Notification | May 2025 |
Cancer Screening and Early Detection
Program | Prevention |
RFA Status | Open |
Description |
Cancer Screening and Early Detection This award mechanism seeks to support the delivery of evidence-based clinical services to screen for cancer and pre-cancer in underserved populations who do not have adequate access to cancer early detection interventions and health care, bringing together networks of public health and community partners to carry out programs tailored for their communities. Projects should identify cancers that cause the most burden in the community, have nationally recommended screening methods, and use evidence-based methods to screen for these cancers. Award: Maximum of $1M for new projects and $2.5M for expansion projects Duration: Maximum 5 years |
Review Cycle | Fiscal Year 2025 - Cycle 2 |
RFA Release | August 26, 2024 |
Application Receipt | September 09, 2024 - December 05, 2024 |
Application Review | January 2025 - April 2025 |
Award Notification | May 2025 |
Dissemination of CPRIT-Funded Cancer Control Interventions
Program | Prevention |
RFA Status | Open |
Description |
Dissemination of CPRIT-Funded Cancer Control Interventions This award mechanism seeks to fund projects that will facilitate the dissemination and implementation of successful CPRIT Prevention Program-funded, evidence-based cancer prevention and control interventions across Texas. The proposed project should be able to develop one or more "products" based on the results of a previously CPRIT Prevention Program-funded intervention project. The proposed project should describe and package strategies or approaches for dissemination to other partners, settings, and populations in the state.
Maximum duration of 3 years |
Review Cycle | Fiscal Year 2025 - Cycle 2 |
RFA Release | August 26, 2024 |
Application Receipt | September 09, 2024 - December 05, 2024 |
Application Review | January 2025 - April 2025 |
Award Notification | May 2025 |
Primary Prevention of Cancer
Program | Prevention |
RFA Status | Open |
Description |
Primary Prevention of Cancer This award mechanism focuses on increasing implementation of evidence-based strategies to ensure that all Texans benefit from the cancer prevention knowledge that we currently have. CPRIT seeks to fund multilevel interventions to reduce cancer risk, disease burden, and cancer disparities. Modifiable risk behaviors include tobacco use, obesity, physical inactivity, unhealthy eating, alcohol use, sun exposure, HPV vaccination, Hepatitis B vaccination, and environmental/ occupational cancer exposures. Applications should also assess and address social determinants that contribute to cancer burden and disparities (e.g., cultural factors, unmet needs, access barriers). Interventions and communications should be structured to address the unique circumstances of the population to be served.
Duration: Maximum 5 years |
Review Cycle | Fiscal Year 2025 - Cycle 2 |
RFA Release | August 26, 2024 |
Application Receipt | September 09, 2024 - December 05, 2024 |
Application Review | January 2025 - April 2025 |
Award Notification | May 2025 |
Recruitment of Established Investigators (REI)
Revised: 08/02/2024
Instructions for Applicants
Revised: 08/02/2024
Program | Academic Research |
RFA Status | Open |
Description |
Recruits outstanding senior research faculty with distinguished professional careers and established cancer research programs to academic institutions in Texas. Award: Up to $6 million over a period of five years. |
Review Cycle | Fiscal Year 2025 - Cycle 1 |
RFA Release | June 21, 2024 |
Application Receipt | June 21, 2024 - June 20, 2025 |
Application Review | September 2024 - July 2025 |
Award Notification | Continuous |
Recruitment of Rising Stars (RRS)
Revised: 08/02/2024
Instructions for Applicants
Revised: 08/02/2024
Program | Academic Research |
RFA Status | Open |
Description |
Recruits outstanding mid-level investigators to Texas, who have developed a track-record as an independent investigator and demonstrated the promise for continued and enhanced contributions to the field of cancer research. Award: Up to $4 million over a period of five years. |
Review Cycle | Fiscal Year 2025 - Cycle 1 |
RFA Release | June 21, 2024 |
Application Receipt | June 21, 2024 - June 20, 2025 |
Application Review | September 2024 - July 2025 |
Award Notification | Continuous |
Recruitment of First-Time, Tenure-Track Faculty Members (RFT)
Revised: 08/02/2024
Instructions for Applicants
Revised: 08/02/2024
Program | Academic Research |
RFA Status | Open |
Description |
Supports very promising emerging investigators, pursuing their first faculty appointment in Texas, who have the ability to make outstanding contributions to the field of cancer research. Award: Up to $2 million up to a period of five years. |
Review Cycle | Fiscal Year 2025 - Cycle 1 |
RFA Release | June 21, 2024 |
Application Receipt | June 21, 2024 - June 20, 2025 |
Application Review | September 2024 - July 2025 |
Award Notification | Continuous |